|Articles|October 30, 2019
HCP Monitoring in Downstream Process Samples
Author(s)PharmaFluidics
μPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
High-throughput Headspace Analysis of Volatile Nitrosamines and their Secondary Amine Precursors
2
Detecting Estrogen Signatures in MCN Tumors via Targeted LC-MS/MS
3
GC-IMS Profiling of Flavor and Quality Changes in Cooked Crayfish
4
Best of the Week: The Scientific Method in the Age of AI, Rewiring the Fundamentals
5
